UK announces large-scale AI project targeting antibiotic-resistant infections

New antibiotics are critically required to combat antimicrobial resistance worldwide. This recently announced Fleming Fund-GSK partnership will invest $59 M in multiple research areas to use artificial intelligence (AI) to design and deliver new drugs against drug-resistant bacterial infections. Click here to read more. 

•   Print
•   Email
•   Share
•   Tweet